Research Article
Short-Term Outcome of Patients with Cirrhosis and Concurrent Portal Cavernoma Presenting with Acute Variceal Bleeding
Table 2
Summary of efficacy measurements during the 5-day period.
| ā | The cavernoma group | The control group | value |
| 5-day treatment failure, (%) | 9 (32.1%) | 7 (12.5%) | 0.031 | Failure to control acute bleeding, (%) | 5 (17.9%) | 3 (5.4%) | 0.066 | Early rebleeding in 5 days, (%) | 4 (14.3%) | 2 (3.6%) | 0.072 | 5-day mortality, (%) | 3 (10.7%) | 2 (3.6%) | 0.192 |
|
|